Lung Cancer Clinical Trial

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

Summary

The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologic or cytologic confirmation of NSCLC (locally advanced or metastatic, IB-IV)
Failure of first-line platinum-based chemotherapy

Exclusion Criteria:

Mixed small cell or non-small-cell histology
Bronchoalveolar carcinoma
Prior chemotherapy or herbal preparations must be discontinued more than 4 weeks before the start of study therapy (6 weeks for nitrosoureas, mitomycin and suramin)
Prior treatment with docetaxel

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

129

Study ID:

NCT00047840

Recruitment Status:

Completed

Sponsor:

Genzyme, a Sanofi Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Research Site
Los Angeles California, , United States
Research Site
Jacksonville Florida, , United States
Research Site
Atlanta Georgia, , United States
Research Site
New Orleans Louisiana, , United States
Research Site
Boston Massachusetts, , United States
Research Site
Pittsfield Massachusetts, , United States
Research Site
Ann Arbor Michigan, , United States
Research Site
Detroit Michigan, , United States
Research Site
Billings Montana, , United States
Research Site
Great Neck New York, , United States
Research Site
New York New York, , United States
Research Site
Durham North Carolina, , United States
Research Site
Coos Bay Oregon, , United States
Research Site
Philadelphia Pennsylvania, , United States
Research Site
Pittsburgh Pennsylvania, , United States
Research Site
Houston Texas, , United States
Research Site
Brno , , Czech Republic
Research Site
Chomutov , , Czech Republic
Research Site
Hradec , , Czech Republic
Research Site
Ostrava , , Czech Republic
Research Site
Plzen , , Czech Republic
Research Site
Praha , , Czech Republic
Research Site
Budapest , , Hungary
Research Site
Debrecen , , Hungary
Research Site
Deszk , , Hungary
Research Site
Torokbalint , , Hungary

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

129

Study ID:

NCT00047840

Recruitment Status:

Completed

Sponsor:


Genzyme, a Sanofi Company

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.